» Authors » W J Louwman

W J Louwman

Explore the profile of W J Louwman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 603
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Roumen R, Schuurman M, Aarts M, Maaskant-Braat A, Vreugdenhil G, Louwman W
PLoS One . 2021 May; 16(5):e0252021. PMID: 34033662
Background: The Multicenter Selective Lymphadenectomy Trial (MSLT-1) comparing survival after a sentinel lymph node biopsy (SLNB) versus nodal observation in melanoma patients did not show a significant benefit favoring SLNB....
2.
Verver D, van der Veldt A, van Akkooi A, Verhoef C, Grunhagen D, Louwman W
Int J Cancer . 2019 Feb; 146(1):26-34. PMID: 30801710
Melanoma of unknown primary (MUP) may have a different biology to melanoma of known primary, but clinical trials of novel therapies (e.g., immune checkpoint or BRAF/MEK inhibitors) have not reported...
3.
Verver D, Louwman W, Koljenovic S, Verhoef C, Grunhagen D, van Akkooi A
Eur J Cancer . 2017 Dec; 92:100-107. PMID: 29217356
Introduction: The 8th American Joint Committee on Cancer (AJCC) staging edition includes revisions regarding pT1 melanomas. We aimed to evaluate the expected impact of this edition on staging and survival...
4.
Verstijnen J, Damude S, Hoekstra H, Kruijff S, Ten Tije A, Louwman W, et al.
Surg Oncol . 2017 Nov; 26(4):431-437. PMID: 29113662
Background: Due to the lack of solid evidence for treatment benefit of Sentinel Lymph Node Biopsy (SLNB) as part of loco-regional surgical treatment of non-distant metastatic melanoma, there might be...
5.
Siesling S, Louwman W, Kwast A, van den Hurk C, OCallaghan M, Rosso S, et al.
Eur J Cancer . 2014 Aug; 51(9):1039-49. PMID: 25131265
Aim: To provide insight into cancer registration coverage, data access and use in Europe. This contributes to data and infrastructure harmonisation and will foster a more prominent role of cancer...
6.
van Steenbergen L, Voogd A, Roukema J, Louwman W, Duijm L, Coebergh J, et al.
Breast . 2013 Dec; 23(1):63-8. PMID: 24291376
Background: To examine variation in time and place in axillary staging and treatment of patients with ductal carcinoma in situ (DCIS) of the breast. Methods: Trends in patients with DCIS...
7.
van Breest Smallenburg V, Nederend J, Voogd A, Coebergh J, van Beek M, Jansen F, et al.
Br J Cancer . 2013 May; 109(1):242-8. PMID: 23695018
Background: Diagnostic surgical breast biopsies have several disadvantages, therefore, they should be used with hesitation. We determined time trends in types of breast biopsies for the workup of abnormalities detected...
8.
Schaapveld M, van den Belt-Dusebout A, Gietema J, de Wit R, Horenblas S, Witjes J, et al.
Br J Cancer . 2012 Oct; 107(9):1637-43. PMID: 23059747
Background: Testicular germ cell tumour (TGCT) patients are at increased risk of developing a contralateral testicular germ cell tumour (CTGCT). It is unclear whether TGCT treatment affects CTGCT risk. Methods:...
9.
Aarts M, Hamelinck V, Bastiaannet E, Coebergh J, Liefers G, Voogd A, et al.
Br J Cancer . 2012 May; 107(1):12-7. PMID: 22596236
Background: The use of sentinel node biopsy (SNB), lymph node dissection, breast-conserving surgery, radiotherapy, chemotherapy and hormonal treatment for breast cancer was evaluated in relation to socioeconomic status (SES) in...
10.
Jobsen J, Aarts M, Siesling S, Klaase J, Louwman W, Poortmans P, et al.
Clin Oncol (R Coll Radiol) . 2011 Oct; 24(1):e1-8. PMID: 21968247
Aims: To describe variation in the utilisation rates of primary radiotherapy for patients with rectal cancer in the Netherlands, focusing on time trends and age effects. Materials And Methods: Data...